English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
Clinical Requirements Regarding In Silico Oncology
Please rate this video
The information in this video was of interest to me
The information in this video is likely to improve my clinical practice or research
I would recommend this video to my colleagues
Published:
23 Jan 2009
Views:
11532
Rating:
Save
Rate video
Professor Norbert Graf, Director of Oncology and Haematology Clinic, University of Saarland
Lecture from the European Union ICT BIO 2008 Conference (Oct. 23-24, 2008) on Clinical Requirements Regarding In Silico Oncology
Categories:
Haematology oncology
Related Videos
ZUMA-7: Axi-cel is superior to standard of care across common prognostic...
Dr Fred Locke - Moffitt Cancer Center, Tampa, USA
23 Dec 2022
Zanubrutinib demonstrates superior PFS compared with ibrutinib for treatment of...
Dr Mazyar Shadman - Fred Hutchinson Cancer Center, Seattle, USA
21 Dec 2022
PTCy/Tac/MMF gives a higher 1-year GVHD/relapse or progression-free survival...
Dr Monzr Al Malki - City of Hope, Duarte, USA
21 Dec 2022
Effective treatment of low risk acute GVHD with itacitinib monotherapy
Prof Aaron Etra - The Tisch Cancer Institute, Mount Sinai, USA
21 Dec 2022
Zanubrutinib improves PFS compared to ibrutinib for R/R chronic lymphocytic...
Dr Jennifer Brown - Dana-Farber Cancer Institute, Boston, USA
19 Dec 2022
Add-on parsaclisib demonstrates improvement in symptoms and SV in MV patients...
Dr Abdulraheem Yacoub - University of Kansas Cancer Center, Kansas City, USA
19 Dec 2022
Consolidation therapy with blinatumomab improves OS in newly diagnosed patients...
Dr Mark Litzow - Mayo Clinic, Rochester, USA
19 Dec 2022
PTCy/Tac/MMF new standard for GVHD prophylaxis in reduced intensity conditioning
Dr Shernan Holtan - University of Minnesota, Minneapolis, USA
15 Dec 2022
Acalabrutinib, venetoclax and obinutuzumab show high rates of clinical response...
Dr Christine Ryan - Dana-Farber Cancer Institute, Boston, USA
15 Dec 2022
More from
e
cancer